Correlation of levetiracetam concentrations between serum and saliva

被引:45
|
作者
Grim, SA
Ryan, M
Miles, MV
Tang, PH
Strawsburg, RH
deGrauw, TJ
Fakhoury, TA
Baumann, RJ
机构
[1] Univ Kentucky, Chandler Med Ctr, Lexington, KY USA
[2] Cincinnati Childrens Hosp, Ctr Med, Cincinnati, OH USA
关键词
D O I
10.1097/00007691-200302000-00009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Purpose: More than 100 drugs have been evaluated for salivary therapeutic drug monitoring since the 1970s. The most studied drugs are the anticonvulsants phenytoin, phenobarbital, and carbamazepine, demonstrating strong correlations between serum and saliva concentrations. No published data exist for levetiracetam (LEV) to the authors' knowledge. This study's objective is to determine the correlation between LEV serum and saliva concentrations. Methods: Investigators identified subjects seen in neurology clinics at the University of Kentucky. Patients were eligible if they agreed to participate in this study, were taking LEV for a minimum of 4 weeks, and if a serum LEV concentration had been ordered by their physician. Patients spit a minimum of 0.25 mL into a cup to obtain saliva samples. Blood samples were obtained by phlebotomy. Results: Serum and saliva LEV concentrations were determined via high performance liquid chromatography (HPLC) in two separate reference laboratories. Linear regression analysis was used to evaluate correlations. Serum and saliva samples were obtained from 40 patients (22 female, 18 male), ranging from 3 to 57 years of age. The mean +/- SD serum LEV concentration for reference laboratory A was significantly lower (P < 0.0001) than reference laboratory B, 23.6 +/- 13.8 mug/mL and 27.0 +/- 16.9 mug/mL, respectively. The mean +/- SD saliva to serum concentration fraction was also different for the two laboratories, i.e., 41.0% +/- 0.15% for lab A and 36.0% +/- 0.15% for lab B (P = 0.001). The correlation coefficients for the two laboratories were similar, 0.87 and 0.86 (both P < 0.0001) for labs A and B, respectively. Conclusion: A significant positive correlation exists between LEV saliva and serum concentrations. The ability to monitor LEV therapy using saliva may provide benefits that include facilitating sample collection and improving the quality of life for persons with epilepsy. Patients with poor venous access, such as children and elderly patients, and persons afraid of needles may particularly benefit from this method.
引用
下载
收藏
页码:61 / 66
页数:6
相关论文
共 50 条
  • [1] Correlation of levetiracetam concentrations between serum and saliva.
    Grim, SA
    Ryan, M
    Miles, MV
    Tang, PH
    Strawsburg, RH
    deGrauw, TJ
    Baumann, RJ
    PHARMACOTHERAPY, 2002, 22 (10): : 1354 - 1354
  • [2] Correlation of lamotrigine concentrations between serum and saliva
    Ryan, M
    Grim, SA
    Miles, MV
    Tang, PH
    Fakhoury, TA
    Strawsburg, RH
    deGrauw, TJ
    Baumann, RJ
    PHARMACOTHERAPY, 2003, 23 (12): : 1550 - 1557
  • [3] Saliva and serum levetiracetam concentrations in patients with epilepsy
    Meearelli, Oriano
    Voti, Pietro Li
    Pro, Stefano
    Romolo, Francesco Saverio
    Rotolo, Maria
    Pulitano, Patrizia
    Accornero, Neri
    Vanacore, Nicola
    THERAPEUTIC DRUG MONITORING, 2007, 29 (03) : 313 - 318
  • [4] The correlation of lamotrigine concentrations between saliva and serum in children with epilepsy
    Zhang, Shen
    wang, li
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 202 - 202
  • [5] COMPLICATIONS IN CORRELATION STUDIES BETWEEN SERUM, FREE SERUM AND SALIVA CONCENTRATIONS OF NITRAZEPAM
    THART, BJ
    WILTING, J
    DEGIER, JJ
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1987, 9 (02): : 127 - 131
  • [6] Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome
    Nagtegaal, E
    Peeters, T
    Swart, W
    Smits, M
    Kerkhof, G
    van der Meer, G
    THERAPEUTIC DRUG MONITORING, 1998, 20 (02) : 181 - 183
  • [7] RELATIONSHIP BETWEEN SERUM AND SALIVA CHLORAMPHENICOL CONCENTRATIONS
    KOUP, JR
    LAU, AH
    BRODSKY, B
    SLAUGHTER, RL
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (05) : 658 - 661
  • [8] RELATIONSHIP BETWEEN DIGOXIN CONCENTRATIONS IN SERUM AND SALIVA
    HUFFMAN, DH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (03) : 310 - 312
  • [9] Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations
    Karas-Ruszczyk, Katarzyna
    Kuczynska, Julita
    Sienkiewicz-Jarosz, Halina
    Kurkowska-Jastrzebska, Iwona
    Bienkowski, Przemyslaw
    Restel, Magdalena
    Samochowiec, Jerzy
    Mierzejewski, Pawel
    THERAPEUTIC DRUG MONITORING, 2017, 39 (03) : 263 - 268
  • [10] QUINIDINE SALIVA CONCENTRATIONS - ABSENCE OF CORRELATION WITH SERUM CONCENTRATIONS AT STEADY-STATE
    NARANG, PK
    CARLINER, NH
    FISHER, ML
    CROUTHAMEL, WG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (05) : 695 - 702